About this trial
This study is being done to see if the investigators can take peripheral blood stem cells from either an adult family member or a closely matched unrelated donor, and run them through a special lab instrument to remove alpha/beta T cells and B cells and then give them to the patient to treat disease. This is an experimental way of doing a hematopoietic stem cell transplant (HSCT). The investigators want to see if the new stem cells will grow without bad graft vs. host disease (GVHD). This treatment approach is experimental in the United States.
Eligibility criteria
Qualifiers
No Human leukocyte antigen (HLA) identical sibling available AND
NO HLA matched unrelated donor available OR urgent need of HSCT precludes time necessary to search for suitable HLA matched unrelated donor AND
Haploidentical donor OR closely matched unrelated donor available and willing to undergo mobilization and apheresis
If subject has genetically confirmed inherited bone marrow failure, related donor must be evaluated for this disorder and testing must be negative.
Disqualifiers
Pregnant
HIV infection
Uncontrolled, serious active infection at screening
Significant serious intercurrent illnesses
Trial design
Treatments tested in this trial
- TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
- CliniMACS® System